156 related articles for article (PubMed ID: 9201554)
1. Effects of the angiotensin AT1 receptor antagonist GRI38950 on haemodynamic function in dogs.
Hunt AA; Hilditch A; Drew GM
J Auton Pharmacol; 1997 Feb; 17(1):1-11. PubMed ID: 9201554
[TBL] [Abstract][Full Text] [Related]
2. Pharmacological effects of GR138950, a novel angiotensin AT1 receptor antagonist.
Hilditch A; Hunt AA; Travers A; Polley J; Drew GM; Middlemiss D; Judd DB; Ross BC; Robertson MJ
J Pharmacol Exp Ther; 1995 Feb; 272(2):750-7. PubMed ID: 7853190
[TBL] [Abstract][Full Text] [Related]
3. Further investigations into the mechanism of the antihypertensive activity of the angiotensin AT1 receptor antagonist, GR138950.
Hilditch A; Prior HM; Drew GM
Br J Pharmacol; 1996 Jun; 118(3):711-9. PubMed ID: 8762098
[TBL] [Abstract][Full Text] [Related]
4. The antihypertensive profile of the angiotensin AT1 receptor antagonist, GR138950, and the influence of potential homeostatic compensatory mechanisms in renal hypertensive rats.
Anderson IK; Drew GM
Br J Pharmacol; 1998 Nov; 125(6):1236-46. PubMed ID: 9863652
[TBL] [Abstract][Full Text] [Related]
5. Investigation of the inhibitory effect of N(G)-nitro-L-arginine methyl ester on the antihypertensive effect of the angiotensin AT1 receptor antagonist, GR138950.
Anderson IK; Drew GM
Br J Pharmacol; 1997 Dec; 122(7):1385-94. PubMed ID: 9421286
[TBL] [Abstract][Full Text] [Related]
6. Cardiovascular effects of GR117289, a novel angiotensin AT1 receptor antagonist.
Hilditch A; Hunt AA; Gardner CJ; Twissell DJ; Polley J; Travers A; Drew GM; Middlemiss D; Ross BC; Robertson MJ
Br J Pharmacol; 1994 Jan; 111(1):137-44. PubMed ID: 8012689
[TBL] [Abstract][Full Text] [Related]
7. Comparison of angiotensin II type 1 receptor blockade and angiotensin-converting enzyme inhibition in pregnant sheep during late gestation.
Forhead AJ; Whybrew K; Hughes P; Broughton Pipkin F; Sutherland M; Fowden AL
Br J Pharmacol; 1996 Sep; 119(2):393-401. PubMed ID: 8886426
[TBL] [Abstract][Full Text] [Related]
8. AT1 angiotensin II receptor inhibition in pacing-induced heart failure: effects on left ventricular performance and regional blood flow patterns.
Clair MJ; Krombach RS; Hendrick JW; Houck WV; Hebbar L; Kribbs SB; Rios G; Whitebread S; Mukherjee R; de Gasparo M; Spinale FG
J Card Fail; 1998 Dec; 4(4):311-23. PubMed ID: 9924853
[TBL] [Abstract][Full Text] [Related]
9. Renal pharmacology of GR138950, a novel non-peptide angiotensin AT1 receptor antagonist.
Clark KL; Robertson MJ; Drew GM
Eur J Pharmacol; 1995 Jul; 280(2):195-203. PubMed ID: 7589186
[TBL] [Abstract][Full Text] [Related]
10. Role of AT2 receptors in the cardiovascular events following microinjection of angiotensin II into the superior colliculus of anaesthetised rats.
D'Amico M; Di Filippo C; Rossi F; Warner TD
Naunyn Schmiedebergs Arch Pharmacol; 1998 Feb; 357(2):121-5. PubMed ID: 9521484
[TBL] [Abstract][Full Text] [Related]
11. Pharmacological profile of valsartan, a non-peptide angiotensin II type 1 receptor antagonist. 3rd communication: hemodynamic effects of valsartan in rats and dogs.
Hayashi N; Yamamoto S; Kometani M; Nakao K
Arzneimittelforschung; 1997 May; 47(5):620-5. PubMed ID: 9205775
[TBL] [Abstract][Full Text] [Related]
12. The role of angiotensin II AT1 receptor in the maintenance of hemodynamics in a canine model of coronary microembolization-induced heart failure.
Wang J; Yi GH; Zhu SM; Gu AG; Popilskis S; Zhang H; Burkhoff D
J Cardiovasc Pharmacol; 1999 Feb; 33(2):335-40. PubMed ID: 10028945
[TBL] [Abstract][Full Text] [Related]
13. Acute and chronic cardiac and regional haemodynamic effects of the novel bradycardic agent, S16257, in conscious rats.
Gardiner SM; Kemp PA; March JE; Bennett T
Br J Pharmacol; 1995 Jun; 115(4):579-86. PubMed ID: 7582475
[TBL] [Abstract][Full Text] [Related]
14. Role of AT1 receptors in the central control of sympathetic vasomotor function.
Head GA
Clin Exp Pharmacol Physiol Suppl; 1996; 3():S93-8. PubMed ID: 8993846
[TBL] [Abstract][Full Text] [Related]
15. A comparison of the cardiovascular effects of sodium nitroprusside and trimethaphan.
Wang HH; Liu LM; Katz RL
Anesthesiology; 1977 Jan; 46(1):40-8. PubMed ID: 831593
[TBL] [Abstract][Full Text] [Related]
16. Effects of CGS 21680, a selective A2A adenosine receptor agonist, on cardiac output and vascular resistance in acute heart failure in the anaesthetized rat.
Nekooeian AA; Tabrizchi R
Br J Pharmacol; 1998 Apr; 123(8):1666-72. PubMed ID: 9605574
[TBL] [Abstract][Full Text] [Related]
17. Effect of AT1 angiotensin-receptor blockade on structure and function of small arteries in SHR.
Li JS; Sharifi AM; Schiffrin EL
J Cardiovasc Pharmacol; 1997 Jul; 30(1):75-83. PubMed ID: 9268224
[TBL] [Abstract][Full Text] [Related]
18. Levosimendan (OR-1259), a myofilament calcium sensitizer, enhances myocardial contractility but does not alter isovolumic relaxation in conscious and anesthetized dogs.
Pagel PS; Harkin CP; Hettrick DA; Warltier DC
Anesthesiology; 1994 Oct; 81(4):974-87. PubMed ID: 7943849
[TBL] [Abstract][Full Text] [Related]
19. A novel alpha 2-adrenoceptor antagonist attenuates the early, but preserves the late cardiovascular effects of intravenous dexmedetomidine in conscious dogs.
Pagel PS; Proctor LT; Devcic A; Hettrick DA; Kersten JR; Tessmer JP; Farber NE; Schmeling WT; Warltier DC
J Cardiothorac Vasc Anesth; 1998 Aug; 12(4):429-34. PubMed ID: 9713732
[TBL] [Abstract][Full Text] [Related]
20. Prolonged systemic and regional haemodynamic effects of intracerebroventricular angiotensin II in conscious sheep.
May CN
Clin Exp Pharmacol Physiol; 1996; 23(10-11):878-84. PubMed ID: 8911729
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
